Scientists created a small antibody that makes certain cancer tumors glow during PET scans. The approach could help doctors quickly determine which patients are most likely to benefit from targeted treatments. Credit: AI/ScienceDaily.com
Researchers at the University of Missouri are developing a new way to determine which cancer patients are most likely to benefit from targeted therapies by illuminating tumors in medical scans.
Barry Edwards, an associate professor of biochemistry in the School of Medicine, recently designed a very small antibody that seeks out EphA2, a protein frequently present in cancer tumors. After creating the antibody, he attached a radioactive marker that makes the molecule visible during a positron emission tomography (PET) scan.
Read Full Article Here
